Fentanyl Withdrawal Symptoms and Timeline
Fentanyl withdrawal is one of the most intense withdrawal experiences — and because fentanyl is now present in virtually all street opioid supply in New Jersey, understanding its withdrawal profile matters for anyone seeking detox. Medically supervised detox at Hope Harbor in Cherry Hill, NJ means you don't have to go through it alone. Call us 24/7 at (732) 523-5239.
Why Fentanyl Withdrawal Is Different from Heroin Withdrawal
Fentanyl is 50–100 times more potent than morphine and significantly more potent than heroin. Unlike heroin — a short-acting opioid that clears the body relatively quickly — fentanyl accumulates in body fat and muscle tissue during chronic use, creating a reservoir that releases slowly. This fat solubility means withdrawal onset may be delayed and the overall duration more prolonged than people expect based on heroin withdrawal timelines.
An additional complication unique to the current NJ drug supply: xylazine ("tranq") is increasingly detected in fentanyl sold throughout South Jersey and the broader Northeast. Xylazine is a veterinary sedative with its own physical dependence and withdrawal syndrome — one that Narcan does not reverse. People using fentanyl in today's market may unknowingly be physically dependent on two substances simultaneously, with distinct withdrawal profiles that require separate clinical management.
Fentanyl Withdrawal Timeline
Hours 12–24: Early Onset
Early fentanyl withdrawal symptoms typically begin 12–24 hours after the last use, though onset can be delayed to 24–36 hours due to fentanyl's tissue accumulation. Initial symptoms include: anxiety and restlessness, excessive yawning, runny nose and watery eyes, mild chills and goosebumps, early sweating, and muscle tension. At this stage, symptoms can feel manageable — but they escalate significantly without medical support.
Hours 24–72: Escalation
The second phase brings sharply intensified symptoms: severe muscle aches and bone pain, abdominal cramping, nausea, vomiting, and diarrhea (often simultaneously — a major dehydration risk), profuse sweating accompanied by cold chills, goosebumps, severe insomnia, and intense, overwhelming drug cravings. This phase is when most people attempting withdrawal alone relapse — not from lack of willpower, but because the physiological distress is genuinely severe.
Days 3–5: Peak Symptoms
Days 3–5 represent the peak of acute fentanyl withdrawal. All the symptoms from the escalation phase are at their most intense. Depression and anxiety can become severe. Insomnia is near-total. The risk of relapse — and therefore fatal overdose from lost tolerance — is highest during this window. Medical management through this phase is critical.
Days 6–10: Gradual Subsidence
Acute symptoms begin to ease, though fatigue, depression, and gastrointestinal discomfort may persist. Sleep slowly begins to return. Cravings remain significant. Most people feel markedly better by day 7–10 compared to peak, but are not yet well — ongoing monitoring and beginning of therapeutic programming is appropriate during this phase.
Weeks 2–4 and Beyond: Post-Acute Withdrawal Syndrome (PAWS)
After acute physical withdrawal resolves, a significant percentage of people experience PAWS — a protracted syndrome involving persistent cravings, sleep disruption, mood instability (including depression and anxiety), cognitive fog, and anhedonia (difficulty experiencing pleasure). PAWS can last weeks to months and is a primary driver of relapse in the 30–90 day post-detox window. PAWS management through continued programming and medication is a key component of long-term recovery support.
The Xylazine Complication
Xylazine — known on the street as "tranq" or "tranq dope" — is a veterinary alpha-2 adrenergic agonist increasingly detected in fentanyl supply throughout New Jersey and the broader Northeast. New Jersey law passed in January 2024 authorizes xylazine test strip distribution at harm reduction centers in recognition of the severity of this contamination.
Clinically, xylazine creates two significant problems in the context of fentanyl withdrawal:
- Independent withdrawal syndrome: Xylazine withdrawal — characterized by extreme agitation, severe anxiety, autonomic instability, and intense dysphoria — occurs alongside opioid withdrawal and requires separate management. Standard opioid withdrawal protocols do not address xylazine dependence.
- Wound care needs: Xylazine causes severe, necrotic skin wounds at injection sites that do not respond to typical wound care approaches. These wounds require specialized medical management independent of the withdrawal process.
If you or someone you know has been using fentanyl in the current NJ market, tell your treatment team immediately. A xylazine-aware clinical protocol significantly improves comfort and safety during detox.
Why Fentanyl Detox Requires Medical Supervision
Multiple factors make fentanyl withdrawal medically dangerous when attempted without supervision:
- Dehydration risk: Simultaneous vomiting and diarrhea during peak withdrawal can cause severe dehydration and electrolyte imbalance — a medical emergency requiring IV fluid replacement.
- Overdose risk during and after withdrawal: Opioid tolerance drops rapidly once withdrawal begins. Someone who uses fentanyl during withdrawal — or within days of completing withdrawal — at their previous dose faces a dramatically elevated risk of fatal overdose. This is why the detox-to-discharge transition is the most dangerous period in opioid addiction.
- Psychiatric risk: Severe depression and anxiety during peak withdrawal can reach crisis-level intensity. Medical monitoring allows for immediate intervention if needed.
- MAT timing: Buprenorphine (Suboxone) must be initiated at the right point in the withdrawal timeline to be effective and to avoid precipitated withdrawal. This requires clinical judgment and monitoring — not a home estimation.
Learn more about our medical detox program in Cherry Hill.
How Fentanyl Withdrawal Is Treated at Hope Harbor
Our medical approach to fentanyl detox follows evidence-based protocols adapted to the current NJ drug supply landscape:
- Suboxone/buprenorphine induction: Initiated when the patient has reached a sufficient withdrawal threshold (typically a COWS score of 8 or higher), buprenorphine eliminates the majority of acute withdrawal symptoms and dramatically reduces craving intensity. This can be continued as long-term medication-assisted treatment (MAT) if clinically indicated.
- Clonidine for autonomic symptoms: Reduces sweating, chills, anxiety, and elevated heart rate and blood pressure associated with opioid withdrawal.
- Comfort medications: Zofran (ondansetron) for nausea, loperamide for diarrhea, non-opioid sleep aids, and targeted support for cramping and muscle pain.
- IV fluids as needed: For patients with significant GI fluid loss.
- Xylazine-aware protocols: Modified management for patients with suspected or confirmed xylazine co-dependence, including appropriate wound care.
- 24/7 medical monitoring: Vital signs, comfort assessment, and clinical response throughout the acute phase.
After detox, we facilitate structured step-down to inpatient rehabilitation or PHP to address the psychological and behavioral dimensions of recovery during the PAWS period, when the overdose risk remains elevated.
Experiencing Fentanyl Withdrawal? Medical Help Is Available 24/7 in Cherry Hill.
Free, confidential assessments. Insurance accepted. Same-day intake available.
Frequently Asked Questions
Acute fentanyl withdrawal typically peaks around days 3–5 and begins to subside by days 7–10. However, post-acute withdrawal syndrome (PAWS) — including cravings, mood disruption, and sleep problems — can persist for weeks to months. Fentanyl's higher tissue accumulation means withdrawal is often more prolonged than with short-acting heroin.
While opioid withdrawal is rarely fatal in otherwise healthy adults, it is severely uncomfortable and carries serious indirect risks — particularly dehydration from prolonged vomiting and diarrhea, and extremely high relapse/overdose risk. The greatest danger of fentanyl withdrawal is relapse: tolerance drops rapidly, and using the same dose after even a few days of abstinence can cause fatal overdose. Medical supervision dramatically reduces this risk.
Yes — buprenorphine (Suboxone) is highly effective at eliminating acute withdrawal symptoms when properly timed and dosed. It requires careful timing (induction after the patient begins experiencing withdrawal symptoms) to avoid precipitated withdrawal. Our medical staff at Hope Harbor manage this process safely and effectively.
Xylazine is increasingly present in fentanyl sold in New Jersey. Xylazine has its own withdrawal syndrome — characterized by extreme agitation, anxiety, and autonomic instability — that Narcan does not reverse and that requires specific medical management separate from opioid withdrawal. If you suspect xylazine exposure, tell your treatment team immediately so they can adjust the protocol.
Ready to Start Recovery? Our Cherry Hill Team is Available 24/7.
Free, confidential assessments. Insurance accepted. Same-day intake available.